Genetic analyses of smoking initiation, persistence, quantity, and age-at-onset of regular cigarette use in Brazilian families: the Baependi Heart Study

Carregando...
Imagem de Miniatura
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
OLIVEIRA, Camila M.
GIOLO, Suely R.
SOLER, Julia P.
ANDRADE, Mariza de
Citação
BMC MEDICAL GENETICS, v.13, article ID 9, 8p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The purpose of this study was to estimate the genetic influences on the initiation of cigarette smoking, the persistence, quantity and age-at-onset of regular cigarette use in Brazilian families. Methods: The data set consisted of 1,694 individuals enrolled in the Baependi Heart Study. The heritability and the heterogeneity in genetic and environmental variance components by gender were estimated from variance components approaches, using the SOLAR (Sequential Oligogenic Linkage Analysis Routines) computer package. The mixed-effects Cox model was used for the genetic analysis of the age-at onset of regular cigarette use. Results: The heritability estimates were high (> 50%) for smoking initiation and were intermediate, ranging from 23.4 to 31.9%, for smoking persistence and quantity. Significant evidence for heterogeneity in variance components by gender was observed for smoking initiation and age-at-onset of regular cigarette use. Genetic factors play an important role in the interindividual variation of these phenotypes in females, while in males there is a predominant environmental component, which could be explained by greater social influences in the initiation of tobacco use. Conclusions: Significant heritabilities were observed in smoking phenotypes for both males and females from the Brazilian population. These data add to the literature and are concordant with the notion of significant biological determination in smoking behavior. Samples from the Baependi Heart Study may be valuable for the mapping of genetic loci that modulate this complex biological trait.
Palavras-chave
Referências
  1. Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844
  2. Andreeva TI, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-106
  3. Brazil, 2011, VIG BRAZ 2010 PROT R, P152
  4. Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653
  5. Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571
  6. Giolo SR, 2009, HUM HERED, V68, P131, DOI 10.1159/000218111
  7. Goode EL, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S102
  8. Hall W, 2002, TOB CONTROL, V11, P119, DOI 10.1136/tc.11.2.119
  9. Hamilton AS, 2006, CANCER EPIDEM BIOMAR, V15, P1189, DOI 10.1158/1055-9965.EPI-05-0675
  10. Hardie TL, 2006, ADDICT BEHAV, V31, P2030, DOI 10.1016/j.addbeh.2006.02.010
  11. Heath AC, 2002, TWIN RES, V5, P113, DOI 10.1375/1369052022983
  12. HEATH AC, 1993, ADDICT BEHAV, V18, P19, DOI 10.1016/0306-4603(93)90005-T
  13. Heath AC, 1999, BEHAV GENET, V29, P395, DOI 10.1023/A:1021670703806
  14. Lerman C, 2003, AM J MED GENET B, V118B, P48, DOI 10.1002/ajmg.b.10003
  15. Lessov-Schlaggar CN, 2006, INT J EPIDEMIOL, V35, P1278, DOI 10.1093/ije/dy1148
  16. Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x
  17. Madden PAF, 1999, BEHAV GENET, V29, P423, DOI 10.1023/A:1021674804714
  18. Madden PAF, 2004, TWIN RES, V7, P82, DOI 10.1375/13690520460741471
  19. Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405
  20. Morley KI, 2007, PSYCHOL MED, V37, P1357, DOI 10.1017/S0033291707000748
  21. Oliveira CM, 2008, BMC MED GENET, V9, P32
  22. Pankratz VS, 2005, GENET EPIDEMIOL, V28, P97, DOI 10.1002/gepi.20043
  23. Giolo SR, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-132
  24. Pergadia ML, 2006, PSYCHOL MED, V36, P963, DOI 10.1017/S0033291706007495
  25. Rose RJ, 2009, HDB BEHAV GENETICS, V1, P411, DOI 10.1007/978-0-387-76727-7_28
  26. Saccone SF, 2007, AM J HUM GENET, V80, P856, DOI 10.1086/513703
  27. S.A.G.E, 2009, S A G E STAT ANAL GE
  28. Sullivan P. F., 1999, NICOTINE TOB RES S2, V1, pS69
  29. Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51
  30. Verzon DJ, 1998, APPL STAT, V37, P87
  31. Vink J, 2005, BEHAV GENET, V35, P397, DOI 10.1007/s10519-004-1327-8
  32. Vink JM, 2004, PHARMACOGENOMICS J, V4, P345, DOI 10.1038/sj.tpj.6500270
  33. World Health Organization, 2008, REP GLOB TOB EP 2008
  34. [Anonymous], 2008, R LANG ENV STAT COMP